beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta thalassemias (βth) are the result of mutations in the β-globin gene.
|
30716678 |
2019 |
beta Thalassemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
β-Thalassemia (BT) is a hereditary disorder characterized by altered hemoglobin beta-chain synthesis amenable to allogeneic HSC transplantation and HSC gene therapy.
|
30830876 |
2019 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the beta-globin gene (HBB) cause beta-thalassaemia and sickle cell anaemia.
|
29853423 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
|
29164808 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta-thalassemia (β-thalassemia) minor is characterized by a mutation in one of the two β-globin genes (HBB) that produce the β-globin chains in the hemoglobin molecule.
|
30395680 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta-thalassemia is a genetic disorder that is caused by variations in the beta-hemoglobin (HBB) gene.
|
29619482 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We now report genetic correction of the beta hemoglobin (HBB) gene in iPSCs derived from a patient with a double heterozygote for hemoglobin E and β-thalassemia (HbE/β-thalassemia), the most common thalassemia syndrome in Thailand and Southeast Asia.
|
29482624 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
With this view in mind, the study aimed to establish a high resolution melting (HRM) curve-based rapid and reliable mutation screening method targeting the mutational hot-spot of South Asian and Southeast Asian countries that encompasses exon-1 (c.1 - c.92), intron-1 (c.92 + 1 - c.92 + 130) and a portion of exon-2 (c.93 - c.217) of the HBB gene which harbors more than 95% of mutant alleles responsible for beta-thalassemia in Bangladesh.
|
29295702 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genotype-phenotype Correlation of β-Thalassemia in Croatian Patients: A Specific HBB Gene Mutations.
|
29240028 |
2018 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Red blood cells free α-haemoglobin pool: a biomarker to monitor the β-thalassemia intermedia variability. The ALPHAPOOL study.
|
28643346 |
2017 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Three novel HBB mutations, c.-140C>G (-90 C>G), c.237_256delGGACAACCTCAAGGGCACCT (FS Cd 78/85 -20 bp), and c.315+2T>G (IVS2:2 T>G). Update of the mutational spectrum of β-Thalassemia in Mexican mestizo patients.
|
28603845 |
2017 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
The First Report of a 290-bp Deletion in β-Globin Gene in the South of Iran.
|
26948378 |
2017 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Then we collected primary skin fibroblast cells from a β-thalassemia patient with HBB -28 (A>G) homozygous mutation.
|
28942539 |
2017 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Prevalence and genetic analysis of α- and β-thalassemia in Baise region, a multi-ethnic region in southern China.
|
26877226 |
2017 |
beta Thalassemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran.
|
29202846 |
2017 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular Characterization of β-Thalassemia Mutations in Central Vietnam.
|
28671035 |
2017 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cooley anemia (CA), or β-thalassemia major, is the most severe form of the disease and occurs when an individual has mutations in both copies of the adult β-globin gene.
|
29296892 |
2017 |
beta Thalassemia
|
0.800 |
Biomarker
|
disease |
BEFREE |
HBB mutations can be roughly divided into two categories: those that cause a dysfunctional protein (such as sickle cell disease but also including varied diseases caused by high-affinity hemoglobins, low-affinity hemoglobins, and methemoglobinemia) and those that cause the insufficient production of HBB protein (β-thalassemia).
|
29127682 |
2017 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The β-haemoglobinopathies, such as sickle cell disease and β-thalassaemia, are caused by mutations in the β-globin (HBB) gene and affect millions of people worldwide.
|
27820943 |
2016 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Molecular Characterization of β-Thalassemia Intermedia in Southeast Iran.
|
27117567 |
2016 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Rapid detection of pathological mutations and deletions of the haemoglobin beta gene (HBB) by High Resolution Melting (HRM) analysis and Gene Ratio Analysis Copy Enumeration PCR (GRACE-PCR).
|
27756326 |
2016 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Disorders resulting from mutations in the hemoglobin subunit beta gene (HBB; which encodes β-globin), mainly sickle cell disease (SCD) and β-thalassemia, become symptomatic postnatally as fetal γ-globin expression from two paralogous genes, hemoglobin subunit gamma 1 (HBG1) and HBG2, decreases and adult β-globin expression increases, thereby shifting red blood cell (RBC) hemoglobin from the fetal (referred to as HbF or α2γ2) to adult (referred to as HbA or α2β2) form.
|
27525524 |
2016 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A small number of deletions accounts for most α-thalassemias; in contrast, there are no predominant HBB deletions causing β-thalassemia.
|
26612711 |
2016 |
beta Thalassemia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Beta thalassemias (βth) are due to mutations in the β-globin gene.
|
27235732 |
2016 |
beta Thalassemia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Beta thalassemia in 31,734 cases with HBB gene mutations: Pathogenic and structural analysis of the common mutations; Iran as the crossroads of the Middle East.
|
27453201 |
2016 |